Profound difference in pharmacokinetics between morin and its isomer quercetin in rats

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 2, 2003, Pages 199-203

  Hou, Y C ^a   Chao, P D L ^a   Ho, H J ^a   Wen, C C ^b   Hsiu, S L ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; FLAVONOL DERIVATIVE; MORIN; MORIN GLUCURONIDE; MORIN SULFATE; QUERCETIN; QUERCETIN GLUCURONIDE; QUERCETIN SULFATE; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG HYDROXYLATION; DRUG STRUCTURE; HERB; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; ISOMER; MALE; MEAN RESIDENCE TIME; NONHUMAN; PLANT; RAT;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; FLAVONOIDS; HALF-LIFE; INTESTINAL ABSORPTION; ISOMERISM; MALE; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0345073630     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702487     Document Type: Article

References (24)

1. Alarcon-De-La-Lastra, C., Martin, M. J., Motilva, V. (1994) Antiulcer and gastroprotective effects of quercetin: A gross and histologic study. Pharmacology 48: 56-62
2. Cook, N. C., Samman, S. (1996) Flavonoids - Chemistry, metabolism, cardioprotective effects, and dietary sources, J. Nutr. Biochem. 7: 66-76
3. Critchfield, J. W., Welsh, C. J., Phang, J. M., Yeh, G. C. (1994) Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem. Pharmacol. 48: 1437-1445
4. Elangovan, V., Sekar, N., Govindasamy, S. (1994) Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. Cancer Lett. 87: 107-113
5. Ferry, D. R., Smith, A., Malkhandi, J., Fyfe, D. W., DeTakats, P. G., Anderson, D., Baker, J., Kerr, D. J. (1996) Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2: 659-668
6. Hertog, M. G. L., Feskens, E. J. M., Hollman, P. C. H., Katan, M. B., Kromhout, D. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 23: 1007-1011
7. Hertog, M. G. L., Kromhout, D., Aravanis, C., Blackburn, H., Buzina, R., Fidanza, F., Giampaoli, S., Jansen, A., Menotti, A., Nedeljkovic, S., Pekkarinen, M., Pekkarinen, B., Simic, S., Toshima, H., Feskens, E. J. M., Hollman, P. C. H., Katan, M. B. (1995) Flavonoid intake and long-term, risk of coronary heart disease and cancer in the the Seven Countries Study. Arch. Intern. Med. 155: 381-386
8. Hollman, P. C., Katan, M. B. (1999) Dietary flavonoids: Intake, health effects and bioavailability. Food Chem Toxicol. 37: 937-942
9. Hollman, P. C., Hertog, M. G., Katan, M. B. (1996) Role of dietary flavonoids in protection against cancer and coronary heart disease. Biochem. Soc. Trans. 24: 785-789
10. Hsiu, S. L., Tsao, C. W., Tsai, Y. C., Ho, H. J., Chao, P. D. L. (2001) Determination of morin, quercetin and their conjugated metabolites in serum. Biol. Pharm. Bull. 24: 967-969
11. Lanson, D. W., Brignall, M. S. (2000) Antioxidants and cancer III: Quercetin. Altern. Med. Rev. 5: 196-208
12. Liu, I. M., Sheu, S. J. (1989) Analysis and processing of Chinese herbal drugs VIII: The study of Sophorae Floe. Am. J. Chin. Med. 17: 179-187
13. Manach, C., Morand, C., Texier, O., Favier, M. L., Agullo, G., Demigne, C., Regerat, F., Remesy, C. (1995) Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J. Nutr. 125: 1911-1922
14. Middleton, E., Kandaswami, C., Theoharides, T. C. (2000) The effect of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52: 673-651
15. Murray, M. (1998) Quercetin: Nature's antihistamine. Better Nutr. 60: 10
16. Ohnishi, E., Bannai, H. (1993) Quercetin potentiates TNF-induced antiviral activity. Antiviral Res. 22: 327-331
17. Ollila, F., Halling, K., Vuorela, P., Vuorela, H., Slotte, J. P. (2001) Characterization of flavonoid-biomembrane interactions. Arch. Biochem. Biophys. 399: 103-108
18. Scambia, G., Ranelletti, F. O., Panici, P. B., De Vicenzo, R., Bonanno, G., Ferrandina, G., Piantelli, M., Bussa, S., Rumi, C., Cianfriglia, M. (1994) Quercetin potentiates the effect of adrimaycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol. 34: 459-464
19. Spencer, J. P., Chowrimootoo, G., Choudhury, R., Debnam, E. S., Srai, S. K., Rice-Evans, C. (1999) The small intestine can both absorb and glucuronidate luminal flavonoids. Fed. Eur. Biochem. Soc. Lett. 458: 224-230
20. Tanaka, T., Kawabata, K., Honjo, S., Kohno, H., Murakami, M., Shimada, R., Matsunaga, K., Yamada, Y., Shimizu, M. (1999) Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounds, caffeine, quercetin and morin. Oncology Rep. 6: 1333-1340
21. Vinson, J. A., Dabbagh, Y. A., Serry, M. M., Jang, J. (1995) Plant flavonoids, especially tea flavonoids, are powerful anti-oxidants using an in vitro oxidation model for heart disease. J. Agric. Food Chem. 43: 2800-2802
22. Wu, T. W., Fung, K. P., Yang, C. C., Weisel, R. D. (1995a) Antioxidation of human low density lipoprotein by morin hydrate. Life Sci. 57: 51-56
23. Wu, T. W., Fung, K. P., Zeng, L. H., Wu, J. (1995b) Molecular properties and myocardial salvage effects of morin hydrate. Biochem. Pharmacol. 49: 537-573
24. Zeng, L. H., Fung, K. P., Wu, T. W. (1994) Morin hydrate protects cultured rat glomerular mesangial cells against oxyradical damage. Life Sci. 55: PL351-PL357